News
Academy
Publications
All PublicationsE-Books
Media
Editorial PodcastsEditorial VideosPeer ExchangePractice AcademySponsored PodcastsSponsored Videos
More
Conferences
Conference CoverageConference Listing
Columns
All ColumnsA Closing ThoughtClinical Trial InsightsView from BrusselsView from Washington
Resources
AdvertiseBlogsEventsFront & CenterPartner PerspectivesWhite Papers
Webcasts

Subscribe

  • News
  • Academy
  • Publications
  • Media
  • Conferences
  • Columns
  • Resources
  • Webcasts
  • Subscribe
  • Clinical Operations & Strategy
    • Decentralized Clinical Trials
    • Trial Design
    • Investigative Sites
    • CRO/Sponsor
    • Risk-Based Monitoring
    • Protocol Design
    • Clinical Trial Supply Chain
    • Study Start-Up
    • Early Phase Development
  • DEI
    • Industry Initiatives
    • Diversity Action Plans
    • Recruitment
  • Data Management
    • Analytics
    • Electronic Data Capture
    • Real World Evidence
    • Metrics & Benchmarks
  • Patient Participation
    • Integrated Research
    • CRAACO
    • Enrollment
  • Regulatory
    • Institutional Review Board & Ethics Committee
    • FDA
    • EMA
  • Technology
    • Artificial Intelligence/Machine Learning
    • eClinical
    • mHealth
Spotlight -
Conference Coverage|
Peer Exchange|
DE&I|
Editorial Videos|
CNS Drug Development Resources
Advertisement

David Forster, JD, MA, CIP

Advertisement

Chief Compliance Officer, WCG

Articles by David Forster, JD, MA, CIP

Reviewing FDA’s Proposed IRB and Informed Consent Rule Changes

ByDavid Forster, JD, MA, CIP
January 26th 2023

21st Century Cures Act prompts FDA to harmonize regulations.

Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Applied Clinical Trials Online

    1

    De-Risking Development: Prioritizing Robustness in Trial Design

    2

    New Phase II Data Suggest Maternal Nipocalimab Does Not Disrupt Infant Immune Development in Severe HDFN

    3

    SCOPE Summit 2026: Where AI Is Making the Most Immediate Impact Across R&D

    4

    Clinical Operations Teams Adjust to Evidence and Engagement Gaps

    5

    Meeting Halfway: Co-Developing Frameworks for Seamless FSO to FSP Transitions

    • About
    • Advertise
    • Contact Us
    • Editorial Contacts
    • Do Not Sell My Personal Information
    • Privacy Policy
    • Terms and Conditions
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    609-716-7777

    • Applied Clinical Trials
    • BioPharm International
    • Cannabis Science and Technology
    • Chromatography Online
    • Nutritional Outlook
    • Pharmaceutical Commerce
    • Pharmaceutical Executive
    • Pharm Tech
    • Spectroscopy Online
    • Turbo Machinery Magazine
    IS1
    Brand Logo

    © 2025 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us